The big news over the weekend has been Facebook Inc.’s (NSDQ:FB) announcement to buy backstock worth $6B, starting in Q1 2017. This was a first in the history of the company. While it can come across as a surprise for a growing company to announce a share repurchase offering, the recent drop in FB stock price could have forced the management into action. The FB stock price is down by over....More>>>
Piper Jaffray’s Joshua Schimmer and team offer their take on the Biogen (BIIB) takeover speculation that sent shares of the biotech giant soaring this afternoon:
Bloomberg News/Scott Eisen
Biogenshares are trading higher on a WSJ report which indicates the company may have interest from prospective pharma buyers. The WSJ is one of the more credible sources for such speculation....More>>>
Apple Inc. stock is up 18% in the year-to-date. Bullish investor sentiment and a potential iPhone supercycle could lift AAPL stock even higher.
Cupertino, California-based Apple (NASDAQ:AAPL) has recently been in the news, mostly for the right reasons. Barring the chatter regarding its appeal against the European Union’s $14B tax charge, Apple is enjoying a lot of positive....More>>>
Three energy-related IPOs plan to raise about $750 million in the week ahead. Two have direct exposure to oil prices, including Extraction Oil & Gas, which plans to raise $550 million as the first E&P to go public in over two years. An oilfield services company and an India-based solar power producer round out the group.
Renaissance Capital’s IPO Calendar – Week of....More>>>
Heres a roundup of everything we covered on Barrons Stocks to Watch today:
Andy Newman/Associated Press
It was a big day for specialty pharmaceutical companies. We dug into Valeant Pharmaceutical International’s (VRX) 25% surge following its guidance and thebeginning of its asset sales, and Endo International’s (ENDP) 22% rise following its own earnings.